Life ScienceCompany
Coherus Biosciences M&A Summary
Coherus Biosciences has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.
Coherus Biosciences’ largest acquisition to date was in 2023, when it acquired Surface Oncology for $65M. It’s largest disclosed sale occurred in 2024, when it sold Cimerli to Sandoz International for $170M. Coherus Biosciences has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Coherus Biosciences Business Overview
Where is Coherus Biosciences headquartered?
Coherus Biosciences is headquartered in Redwood City, California.
What is Coherus Biosciences’ revenue?
Coherus Biosciences disclosed revenue of 257M USD for 2023 and 211M USD for 2022.
How many employees does Coherus Biosciences have?
Coherus Biosciences has 249 employees.
What sector is Coherus Biosciences in?
Coherus Biosciences is a life science company.
When was Coherus Biosciences founded?
Coherus Biosciences was founded in 2010.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
- M&A Advisors 4